Leukine and Paclitaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Leukine (sargramostim) and Paclitaxel (paclitaxel). Common drug interactions include haemorrhage intracranial among females and rigors among males.

The phase IV clinical study analyzes what interactions people have when they take Leukine and Paclitaxel. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Leukine?

Leukine has active ingredients of sargramostim. eHealthMe is studying from 2,188 Leukine users. Check the latest studies of Leukine.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.



On Jul, 09, 2026

27 people who take Leukine and Paclitaxel together, and have interactions are studied.

Leukine and Paclitaxel drug interactions.

What are the common drug interactions of Leukine and Paclitaxel, by gender? *:

female:

  1. Haemorrhage intracranial (bleeding within the skull)
  2. Leukopenia (less number of white blood cells in blood)
  3. Bladder necrosis
  4. Urinary tract infection
  5. Chest pain
  6. Hyperhidrosis (abnormally increased sweating)
  7. Injection site reaction
  8. Pallor
  9. Abdominal pain lower
  10. Arthralgia (joint pain)

male:

  1. Rigors (an episode of shaking or exaggerated shivering)
  2. Hypertension (high blood pressure)
  3. Hyperventilation
  4. Lung neoplasm malignant (cancer tumour of lung)
  5. Malignant neoplasm progression (cancer tumour came back)
  6. Metastases to neck (cancer spreads to neck)
  7. Pain
  8. Pyrexia (fever)
  9. Respiratory disorder (respiratory disease)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the common drug interactions of Leukine and Paclitaxel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypersensitivity
  2. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

40-49:

  1. Chills (felling of cold)
  2. Device related infection
  3. Drug hypersensitivity
  4. Injection site reaction
  5. Pain
  6. Skin disorder (skin disease)

50-59:

  1. Chest pain
  2. Hyperhidrosis (abnormally increased sweating)
  3. Pallor
  4. Cardiospasm (heart spasm)
  5. Lung neoplasm malignant (cancer tumour of lung)
  6. Malignant neoplasm progression (cancer tumour came back)
  7. Metastases to neck (cancer spreads to neck)
  8. Pyrexia (fever)
  9. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  10. Rigors (an episode of shaking or exaggerated shivering)

60+:

  1. Haemorrhage intracranial (bleeding within the skull)
  2. Leukopenia (less number of white blood cells in blood)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Hypertension (high blood pressure)
  5. Hyperventilation
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Muscle cramp (painful sensation caused by muscle contraction)
  8. Myalgia (muscle pain)
  9. Pain
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 9 people, 33.33%
  2. Ovarian Cancer (cancer of ovary): 7 people, 25.93%
  3. Urinary Tract Infection: 6 people, 22.22%
  4. Stress And Anxiety: 6 people, 22.22%
  5. Bacteraemia (presence of bacteria in the blood): 6 people, 22.22%
  6. Depression: 6 people, 22.22%
  7. Diarrhea: 6 people, 22.22%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 22.22%
  9. Haemoglobin Decreased: 6 people, 22.22%
  10. High Blood Cholesterol: 6 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Leukine and Paclitaxel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Leukine and Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Leukine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Leukine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paclitaxel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sargramostim and paclitaxel (the active ingredients of Leukine and Paclitaxel, respectively), and Leukine and Paclitaxel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: